Abbott Laboratories (NYSE:ABT) Position Boosted by SlateStone Wealth LLC
SlateStone Wealth LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 209.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 41,733 shares of the healthcare product maker’s stock after purchasing an additional 28,259 shares during […]
More Stories
Ferrovial SE (NASDAQ:FER) Given Consensus Rating of “Hold” by Analysts
Ferrovial SE (NASDAQ:FER – Get Free Report) has earned an average rating of “Hold” from the five brokerages that are...
Head to Head Comparison: COMPASS Pathways (NASDAQ:CMPS) & Cencora (NYSE:COR)
COMPASS Pathways (NASDAQ:CMPS – Get Free Report) and Cencora (NYSE:COR – Get Free Report) are both medical companies, but which...
Exelon Corporation (NASDAQ:EXC) Receives Consensus Rating of “Hold” from Analysts
Shares of Exelon Corporation (NASDAQ:EXC – Get Free Report) have been assigned a consensus recommendation of “Hold” from the ten...
Critical Review: Tetra Tech (NASDAQ:TTEK) vs. Media Pal (OTCMKTS:MPHD)
Tetra Tech (NASDAQ:TTEK – Get Free Report) and Media Pal (OTCMKTS:MPHD – Get Free Report) are both industrials companies, but...
Autoliv, Inc. (NYSE:ALV) Given Average Recommendation of “Moderate Buy” by Analysts
Autoliv, Inc. (NYSE:ALV – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty brokerages that...
Artivion, Inc. (NYSE:AORT) Receives $32.00 Consensus Target Price from Analysts
Artivion, Inc. (NYSE:AORT – Get Free Report) has earned an average rating of “Buy” from the seven brokerages that are...